Find Federal Grants
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional)
National Institutes of Health · PA-23-044
Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-252
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01)
National Institutes of Health · PAR-23-040
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed)
National Institutes of Health · PAR-23-039
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-248
South Africa USAID-Pretoria · 72067423RFA00004
National Center for a System of Services for Children and Youth with Special Health Care Needs
Health Resources and Services Administration · HRSA-23-075
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-032
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-239
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
National Institutes of Health · PAR-22-249
Health Resources and Services Administration · HRSA-23-045
Achieving and Sustaining HIV/TB Epidemic Control in the KwaZulu-Natal Province Achieving and Sustaining HIV/TB Epidemic Control in the KwaZulu-Natal Province
South Africa USAID-Pretoria · 72067423RFA00003
Utilizing Telomere Status to Reveal Molecular Mechanisms Underlying Susceptibility and Resiliency in Response to Environmental Exposures (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-ES-22-007
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DK-22-039
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
National Institutes of Health · PAR-23-021
Health Resources and Services Administration · HRSA-23-038
Health Resources and Services Administration · HRSA-23-070
Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-24-007
Developing a Public Health Tool to Predict the Virality of Vaccine Misinformation Narratives
Centers for Disease Control and Prevention - ERA · RFA-IP-23-006
Ryan White HIV/AIDS Program (RWHAP) Integrated HIV/AIDS Planning and Resource Allocation Cooperative Agreement
Health Resources and Services Administration · HRSA-23-054